Morton G - Search Results

1

Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.

Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Bahary JP, Lau H, Duclos M, Parliament M, Morton G, Hamstra D, Seider M, Lock MI, Patel M, Gay H, Vigneault E, Winter K, Sandler H. Michalski JM, et al. Among authors: morton g. JAMA Oncol. 2018 Jun 14;4(6):e180039. doi: 10.1001/jamaoncol.2018.0039. Epub 2018 Jun 14. JAMA Oncol. 2018. PMID: 29543933 Free PMC article. Clinical Trial.

2

Early prostate cancer.

Morton GC. Morton GC. Curr Probl Cancer. 2000 Jan-Feb;24(1):5-51. doi: 10.1016/s0147-0272(00)90007-2. Curr Probl Cancer. 2000. PMID: 10749454 Review. No abstract available.

3

The role of serial transrectal ultrasonography in a 'watchful waiting' protocol for men with localized prostate cancer.

Hruby G, Choo R, Klotz L, Danjoux C, Murphy J, Deboer G, Morton G, Rakovitch E, Szumacher E, Fleshner N. Hruby G, et al. Among authors: morton g. BJU Int. 2001 May;87(7):643-7. doi: 10.1046/j.1464-410x.2001.02133.x. BJU Int. 2001. PMID: 11350404

4

PSA doubling time of prostate carcinoma managed with watchful observation alone.

Choo R, DeBoer G, Klotz L, Danjoux C, Morton GC, Rakovitch E, Fleshner N, Bunting P, Kapusta L, Hruby G. Choo R, et al. Among authors: morton gc. Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):615-20. doi: 10.1016/s0360-3016(01)01511-5. Int J Radiat Oncol Biol Phys. 2001. PMID: 11395227 Clinical Trial.

5

Controversies in prostate cancer radiotherapy: consensus development.

Lukka H, Warde P, Pickles T, Morton G, Brundage M, Souhami L; Canadian GU Radiation Oncologist Group. Lukka H, et al. Among authors: morton g. Can J Urol. 2001 Aug;8(4):1314-22. Can J Urol. 2001. PMID: 11564274 Review.

6

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Choo R, Klotz L, Danjoux C, Morton GC, DeBoer G, Szumacher E, Fleshner N, Bunting P, Hruby G. Choo R, et al. Among authors: morton gc. J Urol. 2002 Apr;167(4):1664-9. J Urol. 2002. PMID: 11912384

7

The role of serial free/total prostate-specific antigen ratios in a watchful observation protocol for men with localized prostate cancer.

Do V, Choo R, De Boer G, Klotz L, Danjoux C, Morton G, Szumacher E, Fleshner N, Bunting P. Do V, et al. Among authors: morton g. BJU Int. 2002 May;89(7):703-9. doi: 10.1046/j.1464-410x.2002.02737.x. BJU Int. 2002. PMID: 11966628

8

(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy.

Choo R, Hruby G, Hong J, Bahk E, Hong E, Danjoux C, Morton G, DeBoer G. Choo R, et al. Among authors: morton g. Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):269-76. doi: 10.1016/s0360-3016(02)02730-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12023129

9

Expectant management with selective delayed intervention for favorable-risk prostate cancer.

Klotz LH, Choo R, Morton G, Danjoux C. Klotz LH, et al. Among authors: morton g. Can J Urol. 2002 Jun;9 Suppl 1:2-7. Can J Urol. 2002. PMID: 12121587 Review.

10

Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?

Yap BK, Choo R, Deboer G, Klotz L, Danjoux C, Morton G. Yap BK, et al. Among authors: morton g. BJU Int. 2003 May;91(7):613-7. doi: 10.1046/j.1464-410x.2003.04169.x. BJU Int. 2003. PMID: 12699470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page